Literature DB >> 18579363

Pentraxins, humoral innate immunity and tissue injury.

Angelo A Manfredi1, Patrizia Rovere-Querini, Barbara Bottazzi, Cecilia Garlanda, Alberto Mantovani.   

Abstract

Tissue damage elicits an inflammatory response, which comprises the rapid synthesis of acute phase molecules. The early local response shapes the resolution of inflammation. Pentraxins are evolutionary conserved soluble pattern recognition receptors, produced in the liver (e.g. C-reactive protein) or at sites of inflammation (the long pentraxin PTX3). Pentraxins behave as flexible adaptors of innate cell functions, complement activation and clearance of cell and matrix debris, regulating tissue hyperplasia and scarring and limiting the risk of autoimmunity associated to unscheduled cell death in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579363     DOI: 10.1016/j.coi.2008.05.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  50 in total

Review 1.  Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis.

Authors:  N Maugeri; P Rovere-Querini; M Baldini; M G Sabbadini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2009-03-20       Impact factor: 4.330

2.  Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis.

Authors:  Gregory G Burrows; Wouter Van't Hof; Laura F Newell; Ashok Reddy; Phillip A Wilmarth; Larry L David; Amy Raber; Annelies Bogaerts; Jef Pinxteren; Robert J Deans; Richard T Maziarz
Journal:  Stem Cells Transl Med       Date:  2013-08-27       Impact factor: 6.940

3.  Constitutive expression of pentraxin 3 (PTX3) protein by human amniotic membrane cells leads to formation of the heavy chain (HC)-hyaluronan (HA)-PTX3 complex.

Authors:  Suzhen Zhang; Ying-Ting Zhu; Szu-Yu Chen; Hua He; Scheffer C G Tseng
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

Review 4.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 5.  The role of defective clearance of apoptotic cells in systemic autoimmunity.

Authors:  Luis E Muñoz; Kirsten Lauber; Martin Schiller; Angelo A Manfredi; Martin Herrmann
Journal:  Nat Rev Rheumatol       Date:  2010-05       Impact factor: 20.543

Review 6.  Wound healing reaction: A switch from gestation to senescence.

Authors:  Maria-Angeles Aller; Jose-Ignacio Arias; Luis-Alfonso Arraez-Aybar; Carlos Gilsanz; Jaime Arias
Journal:  World J Exp Med       Date:  2014-05-20

7.  C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population.

Authors:  Yemil Atisha-Fregoso; Guadalupe Lima; Eduardo Carrillo-Maravilla; Rosalinda Posadas-Sánchez; Nonanzit Pérez-Hernández; Miguel Baños-Peláez; Alejandra Iturralde-Chávez; Nora Hernández-Díaz; Juan Jakez-Ocampo; José Manuel Rodríguez-Pérez; Gilberto Vargas-Alarcón; Luis Llorente; Juanita Romero-Díaz
Journal:  Clin Rheumatol       Date:  2018-03-20       Impact factor: 2.980

8.  Pulmonary chemoreflex responses are potentiated by tumor necrosis factor-alpha in mice.

Authors:  Ruei-Lung Lin; Yu-Jung Lin; Marcus J Geer; Richard Kryscio; Lu-Yuan Lee
Journal:  J Appl Physiol (1985)       Date:  2013-03-28

Review 9.  Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.

Authors:  Marijn M Speeckaert; Reinhart Speeckaert; Juan J Carrero; Raymond Vanholder; Joris R Delanghe
Journal:  J Clin Immunol       Date:  2013-02-27       Impact factor: 8.317

10.  Preoperative methylprednisolone increases plasma Pentraxin 3 early after total knee arthroplasty: a randomized, double-blind, placebo-controlled trial.

Authors:  V Lindberg-Larsen; H Kehlet; K Pilely; J Bagger; M L Rovsing; P Garred
Journal:  Clin Exp Immunol       Date:  2017-11-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.